Injectable Manufacturing Openings in Intas Pharma
30 June 2026

Injectable Manufacturing Openings in Intas Pharma

Injectable - Manufacturing (Aseptic (C-RAPS), Isolator, Ampule). Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world.
30 June 2026
Recruitment Drive for Manufacturing, Packing and QMS at Intas Pharma
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world.
30 June 2026
Analytical Development Apprentice at Amneal Pharmaceuticals
Analytical method development & CMC activity for OSD dosage forms. Perform assigned task with supervision within stipulated time frame. To look for overall analytical development & CMC activity in routine.
30 June 2026
CORONA Remedies Hiring Regulatory Affairs Manager / Sr. Manager
Lead regulatory due diligence and manage global product registrations, renewals, variations, and other regulatory submissions in compliance with timelines.
30 June 2026
NAARI invite Pharma professionals in Production, Packing
Compression, coating, granulation & blending. BMR and logbook maintenance for solid dosage forms. cGMP, SOP compliance, and QMS activities
30 June 2026
Interview for Pharma and Science candidates in QA, QC and Production at Aurobindo Pharma
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India
30 June 2026
Work as Scientific Manager / Principal Scientist at o2h group
Drive multiple medicinal and discovery chemistry projects with on-time, high-quality delivery. Serve as the primary scientific interface for global collaborators and provide strategic technical leadership.
30 June 2026
Zymeworks to Acquire Theravance Biopharma in 929 Million USD Deal, Expanding Into Respiratory Care

Canadian biotechnology company Zymeworks Inc. has signed a definitive agreement to acquire Theravance Biopharma in an all-cash transaction valued at approximately 929 millionUSD , marking a major strategic expansion beyond oncology into respiratory medicine.

Under the terms of the agreement, Theravance shareholders will receive 17.00 USD per share in cash. In addition, they will receive a Contingent Value Right (CVR) that entitles them to 80% of the net proceeds from any future licensing, divestiture, or monetization of ampreloxetine over the next ten years.

30 June 2026
Automated Insulin Delivery Boosts Glucose Control in People with Advanced Kidney Disease, Clinical Trial Finds

People living with diabetes and advanced chronic kidney disease (CKD) may benefit significantly from automated insulin delivery (AID) technology, according to a new international clinical trial. Researchers found that AID systems improved blood glucose control without increasing the risk of severe hypoglycaemia, offering a promising treatment option for one of the most medically complex diabetes populations.

30 June 2026
Merck Opens AI-Powered Global Capability Centre in Bengaluru

Merck has inaugurated its new Merck Global Capability Centre (MGCC) in Bengaluru, marking a significant expansion of its global digital and technology operations in India. The new facility, located in Electronic City, is designed to accelerate the company's digital transformation while strengthening India's position as a strategic innovation hub.